ImmunoCellular Therapeutics Price on January 10, 2023

IMUCDelisted Stock  USD 0.47  0.00  0.00%   
If you're considering investing in ImmunoCellular Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of ImmunoCellular Therapeutics stands at 0.47, as last reported on the 14th of December 2024, with the highest price reaching 0.47 and the lowest price hitting 0.47 during the day. We have found eighteen technical indicators for ImmunoCellular Therapeutics, which you can use to evaluate the volatility of the firm. Please check out ImmunoCellular Therapeutics' Standard Deviation of 11.82, market risk adjusted performance of (0.21), and Risk Adjusted Performance of (0.04) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
ImmunoCellular Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
IMUC
Based on monthly moving average ImmunoCellular Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmunoCellular Therapeutics by adding ImmunoCellular Therapeutics to a well-diversified portfolio.

ImmunoCellular Therapeutics Valuation on January 10, 2023

It is possible to determine the worth of ImmunoCellular Therapeutics on a given historical date. On January 10, 2023 ImmunoCellular was worth 0.61 at the beginning of the trading date compared to the closed value of 0.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ImmunoCellular Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find ImmunoCellular Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ImmunoCellular Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ImmunoCellular Therapeutics' related companies.
 Open High Low Close Volume
  0.71    0.71    0.71    0.71    41.00  
01/10/2023
  0.61    0.61    0.61    0.61    503.00  
  0.77    0.77    0.57    0.60    9,675  
Backtest ImmunoCellular Therapeutics  |  ImmunoCellular Therapeutics History  |  ImmunoCellular Therapeutics Valuation   PreviousNext  
Open Value
0.61
0.61
Closing Value
0.61
Upside

ImmunoCellular Therapeutics Trading Date Momentum on January 10, 2023

On January 11 2023 ImmunoCellular Therapeutics was traded for  0.60  at the closing time. The top price for the day was 0.77  and the lowest listed price was  0.57 . The trading volume for the day was 9.7 K. The trading history from January 11, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.64% . The trading delta at closing time against the current closing price is 13.11% .

ImmunoCellular Therapeutics Fundamentals Correlations and Trends

By evaluating ImmunoCellular Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ImmunoCellular Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ImmunoCellular financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About ImmunoCellular Therapeutics Pink Sheet history

ImmunoCellular Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmunoCellular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmunoCellular Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmunoCellular Therapeutics stock prices may prove useful in developing a viable investing in ImmunoCellular Therapeutics
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Immunocellular Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

ImmunoCellular Therapeutics Pink Sheet Technical Analysis

ImmunoCellular Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of ImmunoCellular Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ImmunoCellular Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

ImmunoCellular Therapeutics Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

ImmunoCellular Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

ImmunoCellular Therapeutics December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how ImmunoCellular Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImmunoCellular Therapeutics shares will generate the highest return on investment. By undertsting and applying ImmunoCellular Therapeutics pink sheet market strength indicators, traders can identify ImmunoCellular Therapeutics entry and exit signals to maximize returns

ImmunoCellular Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ImmunoCellular Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ImmunoCellular Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmunoCellular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in ImmunoCellular Pink Sheet

If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators